Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/3870
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlada, ARA-
dc.date.accessioned2025-04-25T11:51:04Z-
dc.date.available2025-04-25T11:51:04Z-
dc.date.issued2001-
dc.identifier.citationAfr. J. Med. Med. Sci. (2001) 30, 57-59en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/3870-
dc.descriptionArticleen_US
dc.description.abstractEffects of nifedipine and verapamil on nicotine-induced hyperglycemia were studied in fasted, anesthetized male rats. Blood glucose was measured using the glucose oxidase method. Nifedipine (0.05-0.20 mg/kg i.p.) significantly reduced nicotineinduced hyperglycemia in a dose - dependent manner. While lower doses (0.1.0-1.0 mg/kg i.p) of verapamil did not affect nicotine-induced hyperglycemia, higher doses 95.0 - 10 mg/kg i.p) of verapamil caused significant reduction but did not abolish it. Both nifedipine and verapamil had no significant effect on the basal blood glucose levels at any dose used. These results seem to suggest that the reduction in nicotine - induced hyperglycemia is related to inhibition of some of the processes by which nicotine induced hyperglycemia.en_US
dc.description.sponsorshipCOLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, NIGERIAen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, NIGERIAen_US
dc.subjectVerapamilen_US
dc.subjectNifedipineen_US
dc.subjectNicotine-induced hyperglycemiaen_US
dc.subjectRaten_US
dc.titleEffects of calcium channel blockers on nicotine-induced hyperglycemia in the raten_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Alada_Effects of calcium channel blockers_2001.pdfArticle9.39 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.